Two Del. Suits Seek Info On $462M Paratek Deal's Losing Bids
Directors and top leaders of Paratek Pharmaceuticals Inc. appear to have taken the company private at a discount despite "significantly" higher offers so they could keep their jobs and pocket payouts...To view the full article, register now.
Already a subscriber? Click here to view full article